Financial Enhancement Group LLC Jazz Pharmaceuticals PLC Transaction History

Financial Enhancement Group LLC

  • $569 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021
SELL
$128.64 - $184.79 $1,929 - $2,771
-15 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$160.2 - $186.42 $2,403 - $2,796
15 New
15 $3,000
Q1 2019

May 14, 2019
SELL
$121.81 - $142.95 $101,467 - $119,077
-833 Closed
0 $0
Q3 2018

Nov 19, 2018
BUY
$161.01 - $180.57 $134,121 - $150,414
833 New
833 $140,000

Others Institutions Holding JAZZ

# of Institutions
513
Shares Held
57.7M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.68B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Financial Enhancement Group LLC Portfolio

Follow Financial Enhancement Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email